Corient Private Wealth’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.61M | Buy |
518,684
+260,308
| +101% | +$1.31M | ﹤0.01% | 998 |
|
|
2025
Q1 | $1.67M | Buy |
258,376
+856
| +0.3% | +$5.55K | ﹤0.01% | 1039 |
|
|
2024
Q4 | $1.89M | Sell |
257,520
-25,545
| -9% | -$188K | ﹤0.01% | 1029 |
|
|
2024
Q3 | $2.12M | Buy |
283,065
+16,968
| +6% | +$127K | ﹤0.01% | 1044 |
|
|
2024
Q2 | $2.37M | Sell |
266,097
-3,815
| -1% | -$34K | ﹤0.01% | 955 |
|
|
2024
Q1 | $2.73M | Buy |
269,912
+2,633
| +1% | +$26.7K | ﹤0.01% | 886 |
|
|
2023
Q4 | $2.69M | Buy |
267,279
+27,115
| +11% | +$273K | ﹤0.01% | 881 |
|
|
2023
Q3 | $2.25M | Sell |
240,164
-838
| -0.3% | -$7.85K | 0.01% | 864 |
|
|
2023
Q2 | $5.91M | Buy |
241,002
+167
| +0.1% | +$4.1K | 0.01% | 584 |
|
|
2023
Q1 | $5.6M | Buy |
+240,835
| New | +$5.6M | 0.02% | 557 |
|